@hottuna
After going through MSB's past announcements and reading what MSB has to say about this trial in the latest Annual Report, I have to agree with you, that this announcement is just a rehash of old stuff.
The cynic inside me can't help but feeling that MSB is so desperate right now that it will try anything to get the share price up before it turns on the Kentgrove facility.
To those who don't believe that there is nothing new in this announcement. Please see the following excerpt from MSB 2016 Annual Report:
Ann: Mesoblast Phase 2 Diabetic Kidney Disease Results Published-MSB.AX, page-32
-
- There are more pages in this discussion • 9 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.33 |
Change
0.045(3.50%) |
Mkt cap ! $1.518B | |||
| Open | High | Low | Value | Volume |
| $1.30 | $1.35 | $1.30 | $2.885M | 2.183M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 15000 | $1.32 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.33 | 7070 | 1 |
View Market Depth
| Last trade - 16.10pm 06/11/2024 (20 minute delay) ? |
| MSB (ASX) Chart |